Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06523062

Short Term Reproducibility of Office White-coat Effect

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
922 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

While a theoretical increase in systolic blood pressure (BP) of 10 mmHg can triple the relative risk of cardiovascular disease (CVD), the potential presence of a white coat effect (WCE) can interfere with the assessment of blood pressure control in the consultation. However, it is often difficult to assess the presence of a white coat effect (a quantitative variable) in general practice because of the difficulties in performing ambulatory BP measurements (self-measurement of blood pressure or ambulatory BP measurements). We have therefore previously described a surrogate concept of WCE obtained during a consultation with a general practitioner. It corresponds to a reduction of 10mmHg or more in systolic BP between the start and the end of the consultation. We have named it 'office white coat effect tail' (OWCET) and we have shown that OWCET, as a dichotomous variable, in a large Italian population cohort, with a follow-up of more than 18 years, was associated with an excess incidence of stroke, myocardial infarction (MI) and CVD and with excess mortality from MI and CVD. This concept appears to be more prevalent in women and is independent of blood pressure variability (regression to the mean). In addition, there is a genuine correlation between WCE and OWCET. To our knowledge, the reproducibility of the OWCET has never been studied, which could distort the relevance of this concept in the context of cardiovascular risk stratification in primary care.

Conditions

Interventions

TypeNameDescription
DEVICEblood pressure measurementautomated blood pressure measurement on 3 occasions at each consultation, twice with one month apart

Timeline

Start date
2024-09-01
Primary completion
2025-08-31
Completion
2025-08-31
First posted
2024-07-26
Last updated
2024-07-26

Source: ClinicalTrials.gov record NCT06523062. Inclusion in this directory is not an endorsement.